Cargando…

Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes

BACKGROUND: Type 1 diabetes mellitus (T1DM) patients are at an increased risk for non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the clinical criteria associated with the diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) among T1DM Egyptian children and adolescents. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Hanaa Reyad, Youness, Eman Refaat, Bedeir, Manar Maher, Abouelnaga, Marwa W., Ezzat, Wafaa M., Elhosary, Yasser, El-Hariri, Hazem Mohamed, Hussein, Mona Abd Elmotaleb A., Ahmed, Heba R., Eladawy, Rasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029237/
https://www.ncbi.nlm.nih.gov/pubmed/36941617
http://dx.doi.org/10.1186/s13098-023-01029-6
_version_ 1784910099718864896
author Abdallah, Hanaa Reyad
Youness, Eman Refaat
Bedeir, Manar Maher
Abouelnaga, Marwa W.
Ezzat, Wafaa M.
Elhosary, Yasser
El-Hariri, Hazem Mohamed
Hussein, Mona Abd Elmotaleb A.
Ahmed, Heba R.
Eladawy, Rasha
author_facet Abdallah, Hanaa Reyad
Youness, Eman Refaat
Bedeir, Manar Maher
Abouelnaga, Marwa W.
Ezzat, Wafaa M.
Elhosary, Yasser
El-Hariri, Hazem Mohamed
Hussein, Mona Abd Elmotaleb A.
Ahmed, Heba R.
Eladawy, Rasha
author_sort Abdallah, Hanaa Reyad
collection PubMed
description BACKGROUND: Type 1 diabetes mellitus (T1DM) patients are at an increased risk for non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the clinical criteria associated with the diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) among T1DM Egyptian children and adolescents. METHODS: 74 T1DM patients aged 8–18 year were enrolled in this cross sectional study. Assessments of Clinical status, anthropometric measures, lipid profile, glycated haemoglobin (HbA1c) and liver enzymes were done. Abdominal Ultrasound evaluation of hepatic steatosis was done. Accordingly, patients were divided into two groups (NAFLD and normal liver group) and compared together. Assessment of liver fibrosis using acoustic radiation force impulse elastography (ARFI) was done. Statistical analysis included; independent t-test, Chi square and Fisher’s Exact, Pearson and Spearman tests and Logistic regression models for factors associated with fatty liver were used when appropriate. RESULTS: In this study; 74 patients were enrolled; 37 males (50%) and 37 females with mean age 14.3 ± 3.0 year. The mean insulin dose was 1.1 ± 0.4 U/kg and mean disease duration was 6.3 ± 3.0 year. NAFLD was detected in 46 cases while 28 cases had normal liver as diagnosed by abdominal ultrasound. Cases with NAFLD had statistically significant higher BMI-Z scores, waist/hip, waist/height and sum of skin fold thicknesses compared to those with normal liver (P < 0.05). The mean value of HbA1c % was significantly higher in NAFLD group (P = 0.003). Total cholesterol, triglycerides and LDL serum levels were significantly elevated (p < 0.05), while the HDL level was significantly lower in NAFLD cases (p = 0.001). Although, serum levels of liver enzymes; ALT and AST were significantly higher among cases with NAFLD than in normal liver group (p < 0.05), their means were within normal. Using the ARFI elastography; NAFLD cases exhibited significant fibrosis (F2, 3 and 4). BMI, patient age and female gender were among risk factors for NAFLD. CONCLUSIONS: NAFLD represents a serious consequence in type 1 diabetic children and adolescents that deserves attention especially with poor glycemic control. NAFLD has the potential to evolve to fibrosis. This study demonstrated a very high prevalence of NAFLD in T1D children and adolescents using US which was (62.2%) with the percent of liver fibrosis among the NAFLD cases (F2-F4) using ARFI elastography was 26%. BMI, age of patients and female gender were detected as risk factors for NAFLD.
format Online
Article
Text
id pubmed-10029237
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100292372023-03-22 Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes Abdallah, Hanaa Reyad Youness, Eman Refaat Bedeir, Manar Maher Abouelnaga, Marwa W. Ezzat, Wafaa M. Elhosary, Yasser El-Hariri, Hazem Mohamed Hussein, Mona Abd Elmotaleb A. Ahmed, Heba R. Eladawy, Rasha Diabetol Metab Syndr Research BACKGROUND: Type 1 diabetes mellitus (T1DM) patients are at an increased risk for non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the clinical criteria associated with the diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) among T1DM Egyptian children and adolescents. METHODS: 74 T1DM patients aged 8–18 year were enrolled in this cross sectional study. Assessments of Clinical status, anthropometric measures, lipid profile, glycated haemoglobin (HbA1c) and liver enzymes were done. Abdominal Ultrasound evaluation of hepatic steatosis was done. Accordingly, patients were divided into two groups (NAFLD and normal liver group) and compared together. Assessment of liver fibrosis using acoustic radiation force impulse elastography (ARFI) was done. Statistical analysis included; independent t-test, Chi square and Fisher’s Exact, Pearson and Spearman tests and Logistic regression models for factors associated with fatty liver were used when appropriate. RESULTS: In this study; 74 patients were enrolled; 37 males (50%) and 37 females with mean age 14.3 ± 3.0 year. The mean insulin dose was 1.1 ± 0.4 U/kg and mean disease duration was 6.3 ± 3.0 year. NAFLD was detected in 46 cases while 28 cases had normal liver as diagnosed by abdominal ultrasound. Cases with NAFLD had statistically significant higher BMI-Z scores, waist/hip, waist/height and sum of skin fold thicknesses compared to those with normal liver (P < 0.05). The mean value of HbA1c % was significantly higher in NAFLD group (P = 0.003). Total cholesterol, triglycerides and LDL serum levels were significantly elevated (p < 0.05), while the HDL level was significantly lower in NAFLD cases (p = 0.001). Although, serum levels of liver enzymes; ALT and AST were significantly higher among cases with NAFLD than in normal liver group (p < 0.05), their means were within normal. Using the ARFI elastography; NAFLD cases exhibited significant fibrosis (F2, 3 and 4). BMI, patient age and female gender were among risk factors for NAFLD. CONCLUSIONS: NAFLD represents a serious consequence in type 1 diabetic children and adolescents that deserves attention especially with poor glycemic control. NAFLD has the potential to evolve to fibrosis. This study demonstrated a very high prevalence of NAFLD in T1D children and adolescents using US which was (62.2%) with the percent of liver fibrosis among the NAFLD cases (F2-F4) using ARFI elastography was 26%. BMI, age of patients and female gender were detected as risk factors for NAFLD. BioMed Central 2023-03-21 /pmc/articles/PMC10029237/ /pubmed/36941617 http://dx.doi.org/10.1186/s13098-023-01029-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Abdallah, Hanaa Reyad
Youness, Eman Refaat
Bedeir, Manar Maher
Abouelnaga, Marwa W.
Ezzat, Wafaa M.
Elhosary, Yasser
El-Hariri, Hazem Mohamed
Hussein, Mona Abd Elmotaleb A.
Ahmed, Heba R.
Eladawy, Rasha
Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes
title Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes
title_full Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes
title_fullStr Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes
title_full_unstemmed Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes
title_short Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes
title_sort clinical and diagnostic characteristics of non-alcoholic fatty liver disease among egyptian children and adolescents with type1 diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029237/
https://www.ncbi.nlm.nih.gov/pubmed/36941617
http://dx.doi.org/10.1186/s13098-023-01029-6
work_keys_str_mv AT abdallahhanaareyad clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes
AT younessemanrefaat clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes
AT bedeirmanarmaher clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes
AT abouelnagamarwaw clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes
AT ezzatwafaam clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes
AT elhosaryyasser clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes
AT elharirihazemmohamed clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes
AT husseinmonaabdelmotaleba clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes
AT ahmedhebar clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes
AT eladawyrasha clinicalanddiagnosticcharacteristicsofnonalcoholicfattyliverdiseaseamongegyptianchildrenandadolescentswithtype1diabetes